BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 26
• 27
• 28
• 31

• Drug Development

  San Antonio Breast Cancer Symposium Release: New Drug Combination is Able to Eradicate Breast Metastases in Mice

  December 18, 2007

   · 

  2 min read
• Drug Development

  Alexza Pharmaceuticals, Inc. Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients Initial Results Expected to be Reported in Q1 2008

  December 18, 2007

   · 

  6 min read
• Drug Development

  Results of Vasogen’s Phase III ACCLAIM Trial Accepted for Publication in The Lancet

  December 18, 2007

   · 

  6 min read
• Business

  CureMark Appoints Preeminent Pediatrics Gastroenterologist

  December 18, 2007

   · 

  2 min read
• Deals

  BioMarin Pharmaceutical Inc. Re-Acquires Rights to Kuvan in Canada From Merck Serono

  December 18, 2007

   · 

  5 min read
• FDA

  Forest Laboratories, Inc. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension

  December 18, 2007

   · 

  6 min read
• Business

  Novalar Pharmaceuticals, Inc. Strengthens Senior Management Team With Key Appointments

  December 18, 2007

   · 

  3 min read
• Deals

  Pfizer Inc. to Acquire CovX Research LLC to Extend Biotherapeutics Investment

  December 18, 2007

   · 

  3 min read
• Drug Development

  Critical Outcome Technologies Inc. Announces Intentions to Prepare a Phase 1B Health Canada Clinical Trial Submission

  December 18, 2007

   · 

  1 min read
• Business

  Aldagen, Inc. Appoints Laurence Keller, MD as Chief Medical Officer

  December 18, 2007

   · 

  1 min read